Patents by Inventor Miljenko Dumi?

Miljenko Dumi? has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Polymorph V of torasemide
    Patent number: 7241782
    Abstract: The invention relates to a novel polymorph V of torasemide, to a process for its preparation, to its use as a raw material for the preparation of crystalline modifications I and III of torasemide, to amorphous torasemide modifications and to pharmaceutically acceptable salts of torasemide, to pharmaceutical forms containing the said novel polymorph V of torasemide as the active ingredient as well as to its use.
    Type: Grant
    Filed: September 25, 2000
    Date of Patent: July 10, 2007
    Assignee: PLIVA, farmaceutska industrija, dionicko drustvo
    Inventors: Darko Filić, Miljenko Dumić, Bo{hacek over (z)}ena Klepić, Aleksandar Danilovski, Marijan Tudja
  • Amorphous 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin A, process for preparing the same, and uses thereof
    Patent number: 6936591
    Abstract: Substantially pure amorphous 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin A. In addition, this disclosure is directed to a process for the preparation thereof from crude 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin A via orthorhombic isostructural pseudopolymorphs of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin A, of the general formula I: wherein S represents a water-miscible or water-immiscible organic solvent, characterized by the orthorhombic space group P212121, with average unit cell parameters a=8.2 to 9.7 ?, b=11.5 to 13.5 ?, c=44.5 to 47.0 ?, ?=?=?=90°, wherein a, b and c represent the crystal axes lengths and ?, ? and ? represent the angles between the crystal axes.
    Type: Grant
    Filed: July 21, 2003
    Date of Patent: August 30, 2005
    Assignee: Pliva Pharmaceutical Industry, Incorporated
    Inventors: Miljenko Dumić, Mladen Vinković, Marina Oresic, Ernest Mestrovic, Aleksandar Danilovski, Alojz Dumbovic, Knezevic Zdravka, Gorjana Lazarevski, Darko Filic, Dominik Cincic, Katica Lazaric, Dejan-Kresimir Bucar
  • Crystal modification of torasemide
    Patent number: 6833379
    Abstract: The present invention relates to the characterization of a new crystal modification III of torasemide, to a process for the preparation thereof by the use of controlled acidifying of alkaline solutions of torasemide with inorganic or organic acids with or without addition of a crystal seed, to its use as a raw material for the preparation of the crystal modification I of torasemide and of pharmaceutically acceptable salts of torasemide as well as to pharmaceutical forms containing this new crystal modification III of torasemide.
    Type: Grant
    Filed: March 13, 2002
    Date of Patent: December 21, 2004
    Assignee: Pliva Hrvatska d.o.o.
    Inventors: Darko Filić, Miljenko Dumić, Aleksandar Danilovski, Bo{hacek over (z)}ena Klepić, Ines Fistrić, Marina Ore{hacek over (s)}ić, Jasna Horvat Mikul{hacek over (c)}ić
  • Amorphous torasemide modification
    Patent number: 6767917
    Abstract: The present invention relates to an amorphous torasemide modification, to a process for preparation thereof, to its use as a raw material for the preparation of pharmaceutically acceptable salts of torasemide, to pharmaceutical forms containing the amorphous torasemide modification as well as to its use as a diuretic.
    Type: Grant
    Filed: March 17, 2003
    Date of Patent: July 27, 2004
    Assignee: Pliva d.d.
    Inventors: Darko Filić, Miljenko Dumić, Bo{haeck over (z)}ena Klepić, Aleksandar Danilovski, Marijan Tudja
  • Crystal modification of torasemide
    Patent number: 6399637
    Abstract: The present invention relates to the characterization of a new crystal modification III of torasemide, to a process for the preparation thereof by the use of controlled acidifying of alkaline solutions of torasemide with inorganic or organic acids with or without addition of a crystal seed, to its use a raw material for the preparation of the crystal modification I of torasemide and of pharmaceutically acceptable salts of torasemide as well as to pharmaceutical forms containing this new crystal modification III of torasemide.
    Type: Grant
    Filed: November 5, 1999
    Date of Patent: June 4, 2002
    Assignee: PLIVA, farmaceutska, kemijska, prehrambena i kozmeticka industrija, dionicko drustvo
    Inventors: Darko Filić, Miljenko Dumić, Aleksandar Danilovski, Bo{haeck over (z)}ena Klepić, Ines Fistrić, Marina Ore{haeck over (s)}ić, Jasna Horvat Mikul{haeck over (c)}ić
  • Hydroxylamines with hypoglycemic activity
    Patent number: 5545659
    Abstract: Novel 1-(2-,3- or 4-hydroxylaminobenzensulfonyl-1a,2,6,6 a-tetrahydro-1H,4H-[1,3]-dioxepino[5,6-b]azirines with hypoglycemic activity are prepared by selective reduction of appropriate 1-(2-,3- or 4-nitrobenzenesulfonyl) derivatives.
    Type: Grant
    Filed: February 21, 1995
    Date of Patent: August 13, 1996
    Assignee: PLIVA farmaceutska, kemijska, prehrambena i kozmeticka industrija, dionicko drustvo
    Inventors: Miljenko Dumi c, Darko Fili c, Mladen Vinkovi c, Blanka Jamnicky, Mirela E skinja